MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Zoetis Inc

Closed

SectorHealthcare

152.08 0.68

Overview

Share price change

24h

Current

Min

148.08

Max

152.48

Key metrics

By Trading Economics

Income

-101M

581M

Sales

-83M

2.3B

P/E

Sector Avg

26.846

57.333

EPS

1.4

Dividend yield

1.35

Profit margin

25.076

Employees

13,800

EBITDA

-133M

906M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+34.52% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.35%

2.63%

Next Earnings

6 maj 2025

Next Ex Dividend date

16 lip 2025

Market Stats

By TradingEconomics

Market Cap

-13B

66B

Previous open

151.4

Previous close

152.08

Technical Score

By Trading Central

Confidence

Bullish Evidence

Zoetis Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 lis 2024, 12:47 UTC

Earnings

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6 sie 2024, 11:52 UTC

Earnings

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20 lut 2025, 08:00 UTC

Top News

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13 lut 2025, 13:47 UTC

Earnings

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13 lut 2025, 12:09 UTC

Earnings

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13 lut 2025, 12:08 UTC

Earnings

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13 lut 2025, 12:08 UTC

Earnings

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13 lut 2025, 12:00 UTC

Earnings

Zoetis 4Q EPS $1.29 >ZTS

13 lut 2025, 12:00 UTC

Earnings

Zoetis 4Q Rev $2.32B >ZTS

13 lut 2025, 12:00 UTC

Earnings

Zoetis 4Q Net $581M >ZTS

4 lis 2024, 14:05 UTC

Earnings

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4 lis 2024, 12:06 UTC

Earnings

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4 lis 2024, 12:06 UTC

Earnings

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4 lis 2024, 12:05 UTC

Earnings

Zoetis 3Q Adj EPS $1.58 >ZTS

4 lis 2024, 12:00 UTC

Earnings

Zoetis 3Q Net $682M >ZTS

4 lis 2024, 12:00 UTC

Earnings

Zoetis 3Q EPS $1.50 >ZTS

4 lis 2024, 12:00 UTC

Earnings

Zoetis 3Q Rev $2.39B >ZTS

6 sie 2024, 11:44 UTC

Earnings

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 sie 2024, 11:09 UTC

Earnings

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 sie 2024, 11:08 UTC

Earnings

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 sie 2024, 11:08 UTC

Earnings

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 sie 2024, 11:08 UTC

Earnings

Zoetis 2Q Adj EPS $1.56 >ZTS

6 sie 2024, 11:00 UTC

Earnings

Zoetis 2Q Net $624M >ZTS

6 sie 2024, 11:00 UTC

Earnings

Zoetis 2Q Rev $2.36B >ZTS

6 sie 2024, 11:00 UTC

Earnings

Zoetis 2Q EPS $1.37 >ZTS

2 maj 2024, 17:43 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 maj 2024, 13:06 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 maj 2024, 11:27 UTC

Earnings

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 maj 2024, 11:00 UTC

Earnings

Zoetis 1Q Net $599M >ZTS

2 maj 2024, 11:00 UTC

Earnings

Zoetis 1Q EPS $1.31 >ZTS

Peer Comparison

Price change

Zoetis Inc Forecast

Price Target

By TipRanks

34.52% upside

12 Months Forecast

Average 204.88 USD  34.52%

High 242 USD

Low 165 USD

Based on 8 Wall Street analysts offering 12 month price targets forZoetis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

147 / 152.64Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.